Association of metabolic abnormalities and the risk of hepatic fibrosis
Abstract Metabolic dysfunction-associated fatty liver disease (MAFLD) is characterized by a range of metabolic abnormalities, and its impact on the U.S. population requires further understanding. This study aimed to investigate the influence of each component of these metabolic abnormalities on hepa...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | npj Gut and Liver |
| Online Access: | https://doi.org/10.1038/s44355-025-00025-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!